Last Updated: 08 Nov 2024
Executive Summary
Masimo Corporation (MASI) is a leading developer and manufacturer of non-invasive monitoring technologies and hospital automation solutions. The company has a strong financial position with a market capitalization of $8.97 billion, EBITDA of $215 million, and EPS of $1.63. Masimo's stock price is currently trading at $161.35, which is below its 52-week high of $173.90 but above its 52-week low of $83.59. The company has a trailing PE ratio of 102.84 and a forward PE ratio of 40. Analysts have a strong buy rating on the stock, with a consensus target price of $155.57.
Company Overview
Masimo Corporation was founded in 1989 and is headquartered in Irvine, California. The company develops, manufactures, and markets non-invasive monitoring technologies and hospital automation solutions. Masimo's products are used in a variety of healthcare settings, including hospitals, clinics, and ambulatory surgery centers. The company's products are designed to improve patient safety and outcomes by providing accurate and reliable monitoring data.
Fundamental Analysis
Masimo Corporation has a strong financial position. The company's revenue has grown steadily in recent years, and its profitability has improved. In the most recent quarter, Masimo reported revenue of $204.26 million and EPS of $1.63. The company's gross profit margin is 52%, and its operating margin is 6%. Masimo has a strong balance sheet with $1.1 billion in cash and equivalents and no debt.
Technical Analysis
Masimo's stock price has been in a downtrend since the beginning of the year. The stock price is currently trading below its 50-day and 200-day moving averages. The relative strength index (RSI) is below 50, which indicates that the stock is oversold. The moving average convergence divergence (MACD) is also below zero, which indicates that the stock is in a downtrend.
Short Term Outlook
The technical analysis suggests that Masimo's stock price is likely to continue to decline in the short term. The stock price is below its moving averages, and the RSI and MACD are both negative. However, the company's strong fundamentals could provide support for the stock price.
Long Term Outlook
The long-term outlook for Masimo Corporation is positive. The company has a strong financial position and a growing product portfolio. The company's products are used in a variety of healthcare settings, and they are designed to improve patient safety and outcomes. As the healthcare industry continues to grow, Masimo is well-positioned to benefit from increased demand for its products.
Analyst Recommendations
Analysts have a strong buy rating on Masimo Corporation's stock. The consensus target price is $155.57, which represents a potential upside of 13% from the current price. Three analysts have a strong buy rating on the stock, three have a buy rating, and three have a hold rating. No analysts have a sell or strong sell rating on the stock.
